Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis

JAMA

Volumn 286, Issue 12, 2001, Pages 1475-1481

  Sanchez, Ana M ^a   Schreiber, George B ^a   Bethel, James ^a   McCurdy, Paul R ^c   Glynn, Simone A ^a   Williams, Alan E ^b,e   Gilcher, Ronald ^d  

^a AMERICAN RED CROSS   (United States)

^b HOLLAND LABORATORY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d Oklahoma Blood Institute   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; SCREENING TEST; TORQUE TENO VIRUS;

EID: 0035955047     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.12.1475     Document Type: Article

References (40)

1. Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects
2. Hereditary hemochromatosis
3. Screening for hemochromatosis
4. Prevalence of haemochromatosis amongst asymptomatic Australians
5. Prevalence of heterozygotes for hemochromatosis in the white population of the United States
6. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
7. Practice guideline development task force of the College of American Pathologists: Hereditary hemochromatosis
8. Management of hemochromatosis
9. Long-term survival in patients with hereditary hemochromatosis
10. Hemochromatosis: The impact of early diagnosis and therapy
11. Blood from patients with hereditary hemochromatosis - A wasted resource?
12. Eligibility and exclusion of hemochromatosis patients as voluntary blood donors
13. Use of blood therapeutically drawn from hemochromatosis patients
14. Blood donation from patients with hemochromatosis
15. Hemochromatosis patients as blood and tissue donors
16. Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood
17. Hepatitis B antigen and antibody in blood donors: An epidemiologic study
18. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors
19. Post-transfusion hepatitis: Current perspectives
20. Paid-versus-volunteer blood donation in the United States: A historical review
21. Transfusion-associated hepatitis B: Past and present
22. Assessment of motivations for return donation among deferred blood donors
23. Monetary blood donation incentives and the risk of transfusion-transmitted infection
24. Direct oral questions to blood donors: The impact on screening for human immunodeficiency virus
25. Estimates of infectious disease risk factors in US blood donors
26. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996
27. A survey of phlebotomy among persons with hemochromatosis
28. Hemochromatosis probands as blood donors
29. The Retrovirus Epidemiology Donor Study (REDS): Rationale and methods
30. Exact confidence limits for an odds ratio in a 2 × 2 table
31. Blood groups differ on donor deferral
32. Routine screening for iron overload/hemochromatosis
33. Hemochromatosis and blood donors: A perspective
34. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative
35. Why do they give the gift of life? A review of research on blood donors since 1977
36. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Inter-organizational Task Force on Nucleic Acid Amplification Testing of Blood Donors